Angela Applebee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Angela Applebee has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Andrew D. Goodman
Department of Neurology, University of Rochester Medical Center, Rochester, New York
1 shared publicationAndrew R. Blight
Acorda Therapeutics, Inc, Ardsley, New York
1 shared publicationAngeli S. Mayadev
Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, Washington
1 shared publicationB. D. Kirkpatrick
Burlington, VT
1 shared publicationEnrique J. Carrazana
Acorda Therapeutics, Inc, Ardsley, New York
1 shared publicationFrancois Bethoux
Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio
1 shared publication
Latest Publications
- Open Access
- 1 December 2015
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (12) , 2780-2787
Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial
- 1 December 2015
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (12) , 2780-2787
Open AccessEffects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial
- 2 October 2012
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 52 (s2) , 111-116
The Clinical Overlap of Multiple Sclerosis and Headache
Multiple sclerosis (MS) and migraine headache coexist in many young female patients. Whether this is coincidental or causally linked remains unclear. The presenting symptoms and signs of MS relapse and migraine aura can be similar and should be differentiated by careful history and examination to ensure proper diagnosis and treatment. White matter lesions on magnetic resonance imaging have specific patterns for each entity and also need to be interpreted carefully. Although a clear link has not been established between migraine and MS, numerous studies have been reported assessing risks, prevalence, and causation. Complicating these assessments are the disease‐modifying therapies used to treat MS which have been known to be implicated in causing headache. The recent development of novel treatment options for MS requires practitioners to be aware of polypharmacy and potential drug interactions.
- 2 October 2012
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 52 (s2) , 111-116
The Clinical Overlap of Multiple Sclerosis and Headache
Multiple sclerosis (MS) and migraine headache coexist in many young female patients. Whether this is coincidental or causally linked remains unclear. The presenting symptoms and signs of MS relapse and migraine aura can be similar and should be differentiated by careful history and examination to ensure proper diagnosis and treatment. White matter lesions on magnetic resonance imaging have specific patterns for each entity and also need to be interpreted carefully. Although a clear link has not been established between migraine and MS, numerous studies have been reported assessing risks, prevalence, and causation. Complicating these assessments are the disease‐modifying therapies used to treat MS which have been known to be implicated in causing headache. The recent development of novel treatment options for MS requires practitioners to be aware of polypharmacy and potential drug interactions.
- 2 June 2011
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 12 (10) , 1511-1521
Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability
Introduction: Walking impairment is a clinical hallmark of multiple sclerosis (MS), a chronic neurologic disease characterized by axonal demyelination and dysfunction that results in progressive disability. Until recently, there were no therapies that specifically targeted the axonal dysfunction associated with walking impairment in MS. Areas covered: The purpose of this review is to discuss the unmet need for the treatment of walking impairment in MS patients and to evaluate how a new class of pharmacologic therapies, neurofunctional modifiers, potentially addresses this unmet need. Discussion is based on clinical experience and opinions supported by publications identified in the PubMed literature using the search terms ‘multiple sclerosis’ and ‘mobility OR walking’. Expert opinion: The development and approval of new treatments for MS show promise for improving adherence to therapy and increasing the potential for clinical effectiveness. Renewed emphasis on integrating strategies that target the underl...
- 2 June 2011
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 12 (10) , 1511-1521
Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability
Introduction: Walking impairment is a clinical hallmark of multiple sclerosis (MS), a chronic neurologic disease characterized by axonal demyelination and dysfunction that results in progressive disability. Until recently, there were no therapies that specifically targeted the axonal dysfunction associated with walking impairment in MS. Areas covered: The purpose of this review is to discuss the unmet need for the treatment of walking impairment in MS patients and to evaluate how a new class of pharmacologic therapies, neurofunctional modifiers, potentially addresses this unmet need. Discussion is based on clinical experience and opinions supported by publications identified in the PubMed literature using the search terms ‘multiple sclerosis’ and ‘mobility OR walking’. Expert opinion: The development and approval of new treatments for MS show promise for improving adherence to therapy and increasing the potential for clinical effectiveness. Renewed emphasis on integrating strategies that target the underl...
- Open Access
- 11 April 2007
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (15) , 1230
Intramedullary spinal cord abscess in a healthy woman
- 11 April 2007
- Published by Wolters Kluwer Health in Neurology
- Vol. 68 (15) , 1230
Open AccessIntramedullary spinal cord abscess in a healthy woman